BRAF plus MEK-targeted drugs: a new standard of treatment for BRAF-mutant advanced melanoma
Crossref DOI link: https://doi.org/10.1007/s10555-017-9660-6
Published Online: 2017-03-15
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Queirolo, Paola
Spagnolo, Francesco
License valid from 2017-03-01